Erratum to Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice [Arthritis Res Ther. 2013;15: R192] doi: 10.1186/ar4382;Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice

Arthritis Research and Therapy

Volumn 15, Issue 6, 2013, Pages

  Impellizzeri, Daniela ^a   Esposito, Emanuela ^a   Di Paola, Rosanna ^a   Ahmad, Akbar ^a   Campolo, Michela ^a   Peli, Angelo ^b   Morittu, Valeria M ^c   Britti, Domenico ^c   Cuzzocrea, Salvatore ^a,d  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Department of Health Sciences V le Europa ^*  (Italy)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ALCOHOL; CHEMOKINE; COLLAGEN TYPE 2; CYTOKINE; FREUND ADJUVANT; LUTEOLIN; MALONALDEHYDE; PALMIDROL; ANTIINFLAMMATORY AGENT; ENDOCANNABINOID; ETHANOLAMINE DERIVATIVE; PALMITIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BLOOD LEVEL; CARTILAGE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; EDEMA; EMULSION; EROSION; ERYTHEMA; HISTOPATHOLOGY; INCIDENCE; INJECTION; JOINT; MALE; MODULATION; MOUSE; NONHUMAN; OSTEOLYSIS; TAIL; ANIMAL; BIOSYNTHESIS; DBA MOUSE; EXPERIMENTAL ARTHRITIS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYTOKINES; ENDOCANNABINOIDS; ETHANOLAMINES; IMMUNOHISTOCHEMISTRY; LUTEOLIN; MALE; MICE; MICE, INBRED DBA; PALMITIC ACIDS;

EID: 84889660793     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-016-0999-9     Document Type: Erratum

References (51)

1. Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev 1990, 118:193-232. 10.1111/j.1600-065X.1990.tb00817.x, 2079326.
2. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 1993, 260:355-358. 10.1126/science.7682337, 7682337.
3. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Baggiolini M, Gerber NJ. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 1995, 34:602-609. 10.1093/rheumatology/34.7.602, 7670776.
4. Koda M, Yoshino S, Nakamura H, Asano G. Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells. Nihon Ika Daigaku Zasshi 1996, 63:419-423.
5. Fries JF, Williams CA, Ramey D, Bloch DA. The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993, 36:297-306. 10.1002/art.1780360303, 8452574.
6. Hoareau L, Ravanan P, Gonthier MP, Delarue P, Goncalves J, Cesari M, Festy F, Roche R. Effect of PEA on LPS inflammatory action in human adipocytes. Cytokine 2006, 34:291-296. 10.1016/j.cyto.2006.06.005, 16884908.
7. Farquhar-Smith WP, Jaggar SI, Rice AS. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain 2002, 97:11-21. 10.1016/S0304-3959(01)00419-5, 12031775.
8. Aloe L, Leon A, Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions 1993, 39:C145-C147. 10.1007/BF01972748, 7505999.
9. De Petrocellis L, Davis JB, Di Marzo V. Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 2001, 506:253-256. 10.1016/S0014-5793(01)02934-9, 11602256.
10. Balvers MG, Verhoeckx KC, Meijerink J, Wortelboer HM, Witkamp RF. Measurement of palmitoylethanolamide and other N-acylethanolamines during physiological and pathological conditions. CNS Neurol Disord Drug Targets 2013, 12:23-33.
11. Cuzzocrea S, Mazzon E, Paola RD, Genovese T, Muia C, Caputi AP, Salvemini D. Effects of combination M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Arthritis Rheum 2005, 52:1929-1940. 10.1002/art.21044, 15934059.
12. Volk T, Gerst J, Faust-Belbe G, Stroehmann A, Kox WJ. Monocyte stimulation by reactive oxygen species: role of superoxide and intracellular Ca2+. Inflamm Res 1999, 48:544-549. 10.1007/s000110050501, 10563472.
13. Flohe L. Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes. Mol Cell Biochem 1988, 84:123-131. 10.1007/BF00421046, 3068519.
14. Yi LT, Li CF, Zhan X, Cui CC, Xiao F, Zhou LP, Xie Y. Involvement of monoaminergic system in the antidepressant-like effect of the flavonoid naringenin in mice. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1223-1228. 10.1016/j.pnpbp.2010.06.024, 20603175.
15. Lin LZ, Lu S, Harnly JM. Detection and quantification of glycosylated flavonoid malonates in celery, Chinese celery, and celery seed by LC-DAD-ESI/MS. J Agric Food Chem 2007, 55:1321-1326. 10.1021/jf0624796, 3762694, 17253711.
16. Fejes S, Kery A, Blazovics A, Lugasi A, Lemberkovics E, Petri G, Szoke E. Investigation of the in vitro antioxidant effect of Petroselinum crispum (Mill.) Nym. ex A. W. Hill. Acta Pharm Hung 1998, 68:150-156.
17. Materska M, Piacente S, Stochmal A, Pizza C, Oleszek W, Perucka I. Isolation and structure elucidation of flavonoid and phenolic acid glycosides from pericarp of hot pepper fruit Capsicum annuum L. Phytochemistry 2003, 63:893-898. 10.1016/S0031-9422(03)00282-6, 12895536.
18. Shimoi K, Masuda S, Furugori M, Esaki S, Kinae N. Radioprotective effect of antioxidative flavonoids in gamma-ray irradiated mice. Carcinogenesis 1994, 15:2669-2672. 10.1093/carcin/15.11.2669, 7955124.
19. Paterniti I, Impellizzeri D, Crupi R, Morabito R, Campolo M, Esposito E, Cuzzocrea S. Molecular evidence for the involvement of PPAR-delta and PPAR-gamma in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma. J Neuroinflammation 2013, 10:20. 10.1186/1742-2094-10-20, 3579707, 23374874.
20. Paterniti I, Impellizzeri D, Di Paola R, Navarra M, Cuzzocrea S, Esposito E. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury. J Neuroinflammation 2013, 10:91. 10.1186/1742-2094-10-91, 3728012, 23880066.
21. Impellizzeri D, Esposito E, Mazzon E, Paterniti I, Di Paola R, Morittu VM, Procopio A, Britti D, Cuzzocrea S. Oleuropein aglycone, an olive oil compound, ameliorates development of arthritis caused by injection of collagen type II in mice. J Pharmacol Exp Ther 2011, 33:859-869.
22. Szabo C, Virag L, Cuzzocrea S, Scott GS, Hake P, O'Connor MP, Zingarelli B, Salzman A, Kun E. Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase. Proc Natl Acad Sci USA 1998, 95:3867-3872. 10.1073/pnas.95.7.3867, 19929, 9520459.
23. Olechowski CJ, Truong JJ, Kerr BJ. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 2009, 141:156-164. 10.1016/j.pain.2008.11.002, 19084337.
24. Campbell AM, Zagon IS, McLaughlin PJ. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis. Brain Res 2012, 1472:138-148.
25. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88. 10.1016/0304-3959(88)90026-7, 3340425.
26. Ahmad A, Crupi R, Impellizzeri D, Campolo M, Marino A, Esposito E, Cuzzocrea S. Administration of palmitoylethanolamide (PEA) protects the neurovascular unit and reduces secondary injury after traumatic brain injury in mice. Brain Behav Immun 2012, 26:1310-1321. 10.1016/j.bbi.2012.07.021, 22884901.
27. Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paola R, Genovese T, Britti D, De Maio M, Caputi AP, et al. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Arthritis Rheum 2003, 48:3544-3556. 10.1002/art.11351, 14674008.
28. Cuzzocrea S, Mazzon E, Di Paola R, Muia C, Crisafulli C, Dugo L, Collin M, Britti D, Caputi AP, Thiemermann C. Glycogen synthase kinase-3beta inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin Immunol 2006, 120:57-67. 10.1016/j.clim.2006.03.005, 16631408.
29. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994, 152:3559-3569.
30. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358. 10.1016/0003-2697(79)90738-3, 36810.
31. Mullane KM, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 1985, 14:157-167. 10.1016/0160-5402(85)90029-4, 2997548.
32. Esposito E, Impellizzeri D, Mazzon E, Paterniti I, Cuzzocrea S. Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease. PLoS One 2012, 7:e41880. 10.1371/journal.pone.0041880, 3422290, 22912680.
33. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001, 53:135-159.
34. Filippin LI, Vercelino R, Marroni NP, Xavier RM. Redox signalling and the inflammatory response in rheumatoid arthritis. Clin Exp Immunol 2008, 152:415-422. 10.1111/j.1365-2249.2008.03634.x, 2453196, 18422737.
35. Szabo C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, Perretti M. Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 1997, 186:1041-1049. 10.1084/jem.186.7.1041, 2199068, 9314553.
36. Choi AY, Choi JH, Lee JY, Yoon KS, Choe W, Ha J, Yeo EJ, Kang I. Apigenin protects HT22 murine hippocampal neuronal cells against endoplasmic reticulum stress-induced apoptosis. Neurochem Int 2010, 57:143-152. 10.1016/j.neuint.2010.05.006, 20493918.
37. Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A. N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 1996, 300:227-236. 10.1016/0014-2999(96)00015-5, 8739213.
38. Conti S, Costa B, Colleoni M, Parolaro D, Giagnoni G. Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol 2002, 135:181-187. 10.1038/sj.bjp.0704466, 1573125, 11786493.
39. Genovese T, Esposito E, Mazzon E, Di Paola R, Meli R, Bramanti P, Piomelli D, Calignano A, Cuzzocrea S. Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. J Pharmacol Exp Ther 2008, 326:12-23. 10.1124/jpet.108.136903, 18367664.
40. Boyce JA. Mast cells: beyond IgE. J Allergy Clin Immunol 2003, 111:24-32. quiz 33, 10.1067/mai.2003.60, 12532090.
41. Rice AS, Farquhar-Smith WP, Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 2002, 66:243-256. 10.1054/plef.2001.0362, 12052040.
42. Zuo Y, Perkins NM, Tracey DJ, Geczy CL. Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells. Pain 2003, 105:467-479. 10.1016/S0304-3959(03)00261-6, 14527707.
43. Hom JT, Cole H, Estridge T, Gliszczynski VL. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Clin Immunol Immunopathol 1992, 62:56-65. 10.1016/0090-1229(92)90022-G, 1728980.
44. Dong J, Gao Y, Liu Y, Shi J, Feng J, Li Z, Pan H, Xue Y, Liu C, Shen B, et al. The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis. PLoS One 2010, 5:e8920. 10.1371/journal.pone.0008920, 2811745, 20111721.
45. Ferraccioli G, Bracci-Laudiero L, Alivernini S, Gremese E, Tolusso B, De Benedetti F. Interleukin-1beta and Interleukin-6 in arthritis animal models: roles in the early phase of transition from the acute to chronic inflammation and relevance for human rheumatoid arthritis. Mol Med 2010, 16:552-557. 2972398, 20683549.
46. Esposito E, Cuzzocrea S. Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries. CNS Neurol Disord Drug Targets 2013, 12:55-61. 10.2174/1871527311312010010, 23394520.
47. Dirscherl K, Karlstetter M, Ebert S, Kraus D, Hlawatsch J, Walczak Y, Moehle C, Fuchshofer R, Langmann T. Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation 2010, 7:3. 10.1186/1742-2094-7-3, 2819254, 20074346.
48. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts: differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993, 268:5834-5839.
49. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM. Macrophage inflammatory protein-1 alpha: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994, 93:921-928. 10.1172/JCI117097, 293992, 8132778.
50. Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 2006, 12:3551-3570. 10.2174/138161206778343082, 17017948.
51. Sun GB, Sun X, Wang M, Ye JX, Si JY, Xu HB, Meng XB, Qin M, Sun J, Wang HW, et al. Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicol Appl Pharmacol 2012, 265:229-240. 10.1016/j.taap.2012.10.002, 23051850.